Ergosterol biosynthesis and drug development for Chagas disease

Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease

(2009) A Rassi et al.   HEART

Rational Modification of a Candidate Cancer Drug for Use Against Chagas Disease

(2009) James M. Kraus et al.   JOURNAL OF MEDICINAL CHEMISTRY

Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up

(2009) CD Fernandes et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit

(2009) Chiung-Kuang Chen et al.   PLoS Neglected Tropical Diseases

Absence of CD4+ T Lymphocytes, CD8+ T Lymphocytes, or B Lymphocytes Has Different Effects on the Efficacy of Posaconazole and Benznidazole in Treatment of Experimental Acute Trypanosoma cruzi Infection

(2008) M. L. Ferraz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes

(2008) H. R. Martins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease

(2008) Juan M Bustamante et al.   NATURE MEDICINE

The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and Elimination

(2008) Peter J. Hotez et al.   PLoS Neglected Tropical Diseases

Heteroallyl-containing 5-nitrofuranes as new anti-Trypanosoma cruzi agents with a dual mechanism of action

(2007) Alejandra Gerpe et al.   BIOORGANIC & MEDICINAL CHEMISTRY